Clinical trials
Ischemic Stroke clinical trials
Below are recruiting ischemic stroke clinical trials, each written for real people, not researchers. We’re tracking 554 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06990867RecruitingPhase 2/Phase 3
Improving blood flow recovery after stroke
This trial tests a new approach to restore blood flow in the brain after a stroke. It aims to improve recovery and brain function in people with a blocked large artery.
Long Beach, CaliforniaAges 18–90 - NCT07594301RecruitingPhase 2/Phase 3
Minocycline after successful stroke clot removal in the back brain
This study tests whether an antibiotic called minocycline can reduce brain damage after doctors successfully remove a blood clot from the back of the brain (posterior circulation stroke) using a catheter procedure. The drug may help protect brain tissue and improve recovery.
Wuhan, HubeiAges 18 years+ - NCT04651010Recruiting
MRI study to predict outcomes after clot removal in stroke
This study uses special MRI scans to look for patterns that may predict recovery after a specific type of stroke caused by a blocked brain artery. It may help doctors choose the best treatment and better understand who benefits most from clot removal.
PoitiersAges 18 years+ - NCT06949228RecruitingPhase 2/Phase 3
Intra-Arterial Tenecteplase After Clot Removal for Stroke
This trial tests whether giving a clot-busting drug called tenecteplase directly into the brain artery after a successful mechanical clot removal can improve recovery for people with a certain type of stroke. The goal is to see if it safely helps clear any remaining tiny clots and reduces disability.
Toledo, OhioAges 18–85 - NCT07594314RecruitingPhase 2/Phase 3
Minocycline after stroke clot removal surgery
This trial tests whether minocycline, an antibiotic, can reduce brain damage when given after successful clot removal surgery for acute stroke. The goal is to see if this medication helps patients recover better.
Wuhan, HubeiAges 18 years+ - NCT06924996Enrolling by invitation
Thrombectomy for large stroke in back of the brain
This trial is testing whether a clot removal procedure, called endovascular thrombectomy, can help people who have a large stroke in the back part of the brain. To be eligible, the stroke must be from a blocked artery in the base of the skull, and the stroke must be severe and recent.
Beijing, Beijing MunicipalityAges 18–80 - NCT06920303Recruiting
Comparing two tests for stroke diagnosis
This trial compares a non-invasive ultrasound test (Transcranial Colour Coded Duplex) to a CT angiography scan for diagnosing stroke. It may help find a simpler and safer way to assess strokes and transient ischemic attacks (mini-strokes).
SohagAges Any age - NCT06904911RecruitingPhase 2
Study of tenecteplase into the artery after clot removal for stroke
This study tests a clot-dissolving drug called tenecteplase given directly into the artery after a mechanical thrombectomy (clot removal). The goal is to see if it helps improve blood flow to the small vessels in the brain after the main clot is removed.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06883110Recruiting
Testing traditional Chinese medicine for recent stroke
This trial tests whether a traditional Chinese medicine (Angong Niuhuang pill) made from different sources of a natural ingredient can help people who recently had a moderate stroke caused by a blood clot. It aims to see if the pill can improve recovery.
Wuhan, HubeiAges 18–80 - NCT06843356Recruiting
Rescue artery-opening procedure for delayed stroke worsening
This study tests whether an emergency procedure to open a blocked artery in the back of the brain can help people whose stroke starts mild but then suddenly gets worse days later. The goal is to see if this treatment can limit further brain damage and improve recovery.
Hefei, AnhuiAges 18 years+ - NCT06749834RecruitingPhase 3
Clot-busting drug after stroke in people on newer blood thinners
This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.
Hangzhou, ZhejiangAges 18 years+ - NCT06757764RecruitingPhase 4
Stroke from artery narrowing: testing combination of anti-platelet drugs
This trial tests whether a combination of two or three anti-platelet medicines (like aspirin, clopidogrel, or cilostazol) is safe and works better than one alone for people who had a stroke from a narrowed artery. The goal is to prevent another stroke.
Seoul, Songpa-guAges 20 years+ - NCT06749106Recruiting
Using MRI to find bleeding in neck artery plaque
This study uses MRI scans that are already done as part of your stroke care to look for bleeding inside plaque in the neck arteries. The goal is to see if this bleeding can help predict stroke risk.
MunichAges 18 years+ - NCT07626450Recruiting
Hyperbaric oxygen after stroke clot removal treatment
This study tests whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can help recovery after emergency clot-removal surgery for large blood vessel strokes. The goal is to see if extra oxygen can reduce brain damage and improve outcomes.
Beijing, Beijing MunicipalityAges 18–80 - NCT06733246Recruiting
Ceretrieve Device for acute ischemic stroke treatment
This study tests a new device called Ceretrieve that is designed to remove blood clots from large arteries in the brain for people having a severe ischemic stroke. If you are eligible, you will receive the device treatment (a mechanical thrombectomy) within 24 hours of your first symptoms.
HeidelbergAges 18 years+ - NCT06735898Recruiting
A combined therapy for recovery after intensive care
This trial tests a combination of CYTOFLAVIN (given as an IV and later as a pill) to help people with long-term symptoms after spending time in the ICU. It aims to improve muscle weakness, breathing, swallowing, and energy levels during later stages of rehabilitation.
Yekaterinburg, Sverdlovsk OblastAges 18 years+ - NCT06715007Recruiting
Study on blood thinners and artery health for small vessel stroke
This study tests whether a combination of antiplatelet drugs and artery-stabilizing medication can improve recovery after a small stroke caused by damage to tiny blood vessels in the brain. It may help prevent further strokes and support healing.
Nanjing, JiangsuAges 30–79 - NCT06677970RecruitingPhase 3
Blood Pressure Control After Stroke Thrombectomy
This trial tests whether carefully lowering blood pressure after a mechanical clot removal procedure for stroke can improve outcomes. If you've had a large vessel stroke that was successfully treated with thrombectomy, this study will help guide blood pressure management in the recovery period.
Seoul, SeoulAges 20 years+ - NCT06666764RecruitingPhase 3
Oxygen therapy for stroke patients transferred for clot removal
This trial tests whether giving high-concentration oxygen (normobaric oxygen) during transfer to a hospital that can remove a blood clot can help people with acute ischemic stroke. It is for patients who are being transferred specifically for endovascular therapy (EVT) to remove a large clot in the brain.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06663631RecruitingPhase 1
Hibernation-like therapy for stroke recovery after clot removal
This trial tests if a hibernation-like therapy can improve recovery after a stroke caused by a large blood clot in the brain. It is for people who are having a stroke and are scheduled for a procedure to remove the clot.
Linyi, ShandongAges 18–80 - NCT06668649Recruiting
Polish fatigue scale study for MS, ALS, or stroke
This study tests a Polish version of a scale that measures how tired people feel. It's for people with MS, ALS, or stroke, or healthy volunteers.
Krakow, Lesser Poland VoivodeshipAges 18 years+ - NCT06645405Recruiting
AI scan reading for stroke caused by large vessel blockage
This trial tests whether an AI program can better read CT scans to find large blood vessel blockages that cause stroke. If you had a stroke from a blocked large vessel and already had CT scans, the AI may help doctors decide on treatment faster.
Shanghai, Shanghai MunicipalityAges 18–95 - NCT06646601Recruiting
Garden-based program for heart and stroke recovery
This trial tests a preventive program that uses a therapeutic garden to help people with heart or blood vessel conditions. It looks at whether patients find the program helpful and easy to take part in.
GapAges 18 years+ - NCT07635758RecruitingPhase 1/Phase 2
Stem Cell Treatment for Recent Stroke Recovery
This trial tests whether special cells from human placenta can help your brain recover after a recent stroke. The treatment is given as an injection and aims to reduce long-term disability.
BeijingAges 18–80
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ischemic stroke?
- Yes. Clin2 currently lists 554 recruiting ischemic stroke studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ischemic stroke trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ischemic stroke trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.